SOX18 Targeting as a Potential, Viable Therapeutic Avenue for Kaposi Sarcoma
- PMID: 36223085
- DOI: 10.1001/jamadermatol.2022.4341
SOX18 Targeting as a Potential, Viable Therapeutic Avenue for Kaposi Sarcoma
Comment in
-
SOX18 Targeting as a Potential, Viable Therapeutic Avenue for Kaposi Sarcoma-Reply.JAMA Dermatol. 2022 Dec 1;158(12):1459-1460. doi: 10.1001/jamadermatol.2022.4332. JAMA Dermatol. 2022. PMID: 36223092 No abstract available.
Comment on
-
Treatment With Oral Propranolol for Refractory Classic Cutaneous Kaposi Sarcoma.JAMA Dermatol. 2022 Jul 1;158(7):832-834. doi: 10.1001/jamadermatol.2022.1278. JAMA Dermatol. 2022. PMID: 35544086 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
